| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.800 | None | 0.957 | 2 | 0 | 1994 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.600 | None | 0.969 | 8 | 0 | 1990 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.600 | None | 1.000 | 3 | 0 | 1988 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 2000 | 2019 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
group | 0.500 | None | 0.981 | 4 | 0 | 1996 | 2020 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
group | 0.500 | None | 1.000 | 2 | 0 | 1997 | 2016 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 0.963 | 4 | 0 | 1993 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2020 | ||||||||
|
X-linked inhibitor of apoptosis | 0.447 | 0.808 | 0.92 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
peroxiredoxin 1 | 0.485 | 0.846 | 7.7E-10 |
|
group | 0.350 | None | 0.667 | 1 | 0 | 2005 | 2017 | ||||||||
|
RUNX family transcription factor 3 | 0.459 | 0.731 | 0.84 |
|
group | 0.350 | None | 0.833 | 1 | 0 | 2005 | 2017 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2007 | 2015 | ||||||||
|
serpin family B member 3 | 0.565 | 0.615 | 8.2E-16 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2000 | 2011 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.230 | None | 0.750 | 1 | 0 | 2006 | 2017 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
group | 0.140 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
group | 0.100 | None | 0.905 | 3 | 0 | 1996 | 2019 | ||||||||
|
serine peptidase inhibitor Kazal type 7 | 0.722 | 0.308 | 7.8E-02 |
|
group | 0.100 | None | 1.000 | 3 | 0 | 2003 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.944 | 2 | 0 | 2006 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.100 | None | 0.933 | 2 | 0 | 2002 | 2014 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 1998 | 2015 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 2007 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 1998 | 2019 |